Two leading drug development and regulatory consultancies announced they have formed a new strategic alliance to help life science companies navigate an increasingly complex global environment.
Two leading drug development and regulatory consultancies announced they have formed a new strategic alliance to help life science companies navigate an increasingly complex global environment. PharmApprove – a strategic regulatory, and scientific communications consultancy based in the US – and NDA Group – a European-based regulatory, pharmacovigilance and Health Technology Assessment (HTA) consultancy – are collaborating to provide the life science industry with integrated global regulatory, scientific and market access communications solutions.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.